IO Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IO Biotech and buy or sell other stocks, ETFs, and their options commission-free!About IOBTQ
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms.
CEOMai-Britt Zocca, PhD
CEOMai-Britt Zocca, PhD
Employees80
Employees80
HeadquartersCopenhagen, North Denmark
HeadquartersCopenhagen, North Denmark
Founded2014
Founded2014
Employees80
Employees80
IOBTQ Key Statistics
Market cap7.19K
Market cap7.19K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume17.65K
Average volume17.65K
High today$0.0001
High today$0.0001
Low today$0.0001
Low today$0.0001
Open price—
Open price—
Volume10.00K
Volume10.00K
52 Week high$2.08
52 Week high$2.08
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
The current IO Biotech(IOBTQ) stock price is $0.00, with a market capitalization of 7.19K.
IO Biotech(IOBTQ) stock opened on 2026-09-09 at —. The price climbed to $0.00 and dipped to $0.00.
IO Biotech(IOBTQ) shares are trading with a volume of 10K, against a daily average of 17.65K.
During the past year, IO Biotech(IOBTQ) stock moved between $0.00 at its lowest and $2.08 at its peak.
During the past year, IO Biotech(IOBTQ) stock moved between $0.00 at its lowest and $2.08 at its peak.
People also own
Based on the portfolios of people who own IOBTQ. This list is generated using Robinhood data, and it’s not a recommendation.